These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18461136)

  • 1. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain.
    Taylor JG; Nolan VG; Mendelsohn L; Kato GJ; Gladwin MT; Steinberg MH
    PLoS One; 2008 May; 3(5):e2095. PubMed ID: 18461136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.
    Kato GJ; McGowan V; Machado RF; Little JA; Taylor J; Morris CR; Nichols JS; Wang X; Poljakovic M; Morris SM; Gladwin MT
    Blood; 2006 Mar; 107(6):2279-85. PubMed ID: 16291595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leg ulcers in patients with sickle cell disease.
    Koshy M; Entsuah R; Koranda A; Kraus AP; Johnson R; Bellvue R; Flournoy-Gill Z; Levy P
    Blood; 1989 Sep; 74(4):1403-8. PubMed ID: 2475188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
    Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
    Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.
    Nouraie M; Lee JS; Zhang Y; Kanias T; Zhao X; Xiong Z; Oriss TB; Zeng Q; Kato GJ; Gibbs JS; Hildesheim ME; Sachdev V; Barst RJ; Machado RF; Hassell KL; Little JA; Schraufnagel DE; Krishnamurti L; Novelli E; Girgis RE; Morris CR; Rosenzweig EB; Badesch DB; Lanzkron S; Castro OL; Goldsmith JC; Gordeuk VR; Gladwin MT;
    Haematologica; 2013 Mar; 98(3):464-72. PubMed ID: 22983573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.
    Novelli EM; Kato GJ; Ragni MV; Zhang Y; Hildesheim ME; Nouraie M; Barge S; Meyer MP; Hassett AC; Gordeuk VR; Gladwin MT; Isenberg JS
    Am J Hematol; 2012 Mar; 87(3):326-30. PubMed ID: 22318901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype.
    Landburg PP; Teerlink T; Biemond BJ; Brandjes DP; Muskiet FA; Duits AJ; Schnog JB;
    Blood Cells Mol Dis; 2010 Apr; 44(4):229-32. PubMed ID: 20185345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
    Kato GJ; Gladwin MT
    JAMA; 2008 Dec; 300(22):2638-46. PubMed ID: 19066384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
    Antwi-Boasiako C; Campbell AD
    Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia.
    Darbari DS; Onyekwere O; Nouraie M; Minniti CP; Luchtman-Jones L; Rana S; Sable C; Ensing G; Dham N; Campbell A; Arteta M; Gladwin MT; Castro O; Taylor JG; Kato GJ; Gordeuk V
    J Pediatr; 2012 Feb; 160(2):286-90. PubMed ID: 21890147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.
    Gladwin MT; Kato GJ
    Hematology Am Soc Hematol Educ Program; 2005; ():51-7. PubMed ID: 16304359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease.
    Taylor JG; Ackah D; Cobb C; Orr N; Percy MJ; Sachdev V; Machado R; Castro O; Kato GJ; Chanock SJ; Gladwin MT
    Am J Hematol; 2008 Jan; 83(1):6-14. PubMed ID: 17724704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis-associated priapism in sickle cell disease.
    Nolan VG; Wyszynski DF; Farrer LA; Steinberg MH
    Blood; 2005 Nov; 106(9):3264-7. PubMed ID: 15985542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.
    Kato GJ; Gladwin MT; Steinberg MH
    Blood Rev; 2007 Jan; 21(1):37-47. PubMed ID: 17084951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in children and adolescents with sickle cell disease.
    Onyekwere OC; Campbell A; Teshome M; Onyeagoro S; Sylvan C; Akintilo A; Hutchinson S; Ensing G; Gaskin P; Kato G; Rana S; Kwagyan J; Gordeuk V; Williams J; Castro O
    Pediatr Cardiol; 2008 Mar; 29(2):309-12. PubMed ID: 17680298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha thalassemia, but not β
    Hatzlhofer BLD; Pereira-Martins DA; de Farias Domingos I; Arcanjo GDS; Weinhäuser I; Falcão DA; Farias ICC; de Freitas Batista JVG; Prado LPL; Oliveira JMF; Batista THC; Sobreira MJVC; de Santana RM; Araújo ABS; de Melo MA; de Ancântara BV; Coelho-Silva JL; de Moura Rafael ABL; de Lima Silva DM; Albuquerque FP; Santos MNN; Dos Anjos AC; Costa FF; da Silva Araújo A; Lucena-Araújo AR; Bezerra MAC
    Ann Hematol; 2021 Apr; 100(4):921-931. PubMed ID: 33586016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia.
    Ballas SK; Marcolina MJ
    Transfusion; 2006 Jan; 46(1):105-10. PubMed ID: 16398738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
    Morris CR; Kato GJ; Poljakovic M; Wang X; Blackwelder WC; Sachdev V; Hazen SL; Vichinsky EP; Morris SM; Gladwin MT
    JAMA; 2005 Jul; 294(1):81-90. PubMed ID: 15998894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.
    Minniti CP; Sable C; Campbell A; Rana S; Ensing G; Dham N; Onyekwere O; Nouraie M; Kato GJ; Gladwin MT; Castro OL; Gordeuk VR
    Haematologica; 2009 Mar; 94(3):340-7. PubMed ID: 19211639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.